Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells

Virology

Volumn 354, Issue 2, 2006, Pages 252-260

  Gedvilaite, Alma ^a   Dorn, David C ^b   Sasnauskas, Kestutis ^a   Pecher, Gabriele ^b   Bulavaite, Aiste ^a   Lawatscheck, Robert ^b   Staniulis, Juozas ^c   Dalianis, Tina ^d   Ramqvist, Torbjörn ^d   Schönrich, Günther ^b   Raftery, Martin J ^b   Ulrich, Rainer ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c INSTITUTE OF BOTANY   (Lithuania)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Capsid; Dendritic cells; Maturation; Polyomavirus; T cell response; Virus like particles

Indexed keywords

INTERLEUKIN 12; PROTEIN VP1;

ARTICLE; BK VIRUS; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; JC VIRUS; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIMIAN VIRUS 40; T LYMPHOCYTE ACTIVATION; VIRUS PARTICLE;

CAPSID PROTEINS; DENDRITIC CELLS; HUMANS; POLYOMAVIRUS; VIRION;

HAMSTER POLYOMAVIRUS; MIRIDAE; MURINAE; POLYOMAVIRUS; SIMIAN VIRUS 40;

EID: 33749537853     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.007     Document Type: Article

References (49)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
2. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., and Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18 (2000) 767-811
3. Basak S., Turner H., and Compans R.W. Expression of SV40 receptors on apical surfaces of polarized epithelial cells. Virology 190 (1992) 393-402
4. Bolen J.B., and Consigli R.A. Differential adsorption of polyoma virions and capsids to mouse kidney cells and guinea pig erythrocytes. J. Virol. 32 (1979) 679-683
5. Boura E., Liebl D., Spisek R., Fric J., Marek M., Stokrova J., Holan V., and Forstova J. Polyomavirus EGFP-pseudocapsids: analysis of model particles for introduction of proteins and peptides into mammalian cells. FEBS Lett. 579 (2005) 6549-6558
6. Breau W.C., Atwood W.J., and Norkin L.C. Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J. Virol. 66 (1992) 2037-2045
7. Chang D., Fung C.Y., Ou W.C., Chao P.C., Li S.Y., Wang M., Huang Y.L., Tzeng T.Y., and Tsai R.T. Self-assembly of the JC virus major capsid protein, VP1, expressed in insect cells. J. Gen. Virol. 78 (1997) 1435-1439
8. Drake III D.R., Moser J.M., Hadley A., Altman J.D., Maliszewski C., Butz E., and Lukacher A.E. Polyomavirus-infected dendritic cells induce antiviral CD8(+) T lymphocytes. J. Virol. 74 (2000) 4093-4101
9. Drake III D.R., Shawver M.L., Hadley A., Butz E., Maliszewski C., and Lukacher A.E. Induction of polyomavirus-specific CD8(+) T lymphocytes by distinct dendritic cell subpopulations. J. Virol. 75 (2001) 544-547
10. Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Zheng Y., Martin K., Peyerl F.W., Lifton M., Gorgone D., Autissier P., Letvin N.L., and Koralnik I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77 (2003) 11918-11926
11. Fausch S.C., Da Silva D.M., and Kast W.M. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res. 63 (2003) 3478-3482
12. Forstova J., Krauzewicz N., Wallace S., Street A.J., Dilworth S.M., Beard S., and Griffin B.E. Cooperation of structural proteins during late events in the life cycle of polyomavirus. J. Virol. 67 (1993) 1405-1413
13. Franzen A.V., Tegerstedt K., Hollanderova D., Forstova J., Ramqvist T., and Dalianis T. Murine polyomavirus-VP1 virus-like particles immunize against some polyomavirus-induced tumours. In Vivo 19 (2005) 323-326
14. Gedvilaite A., Frömmel C., Sasnauskas K., Micheel B., Özel M., Behrsing O., Staniulis J., Jandrig B., Scherneck S., and Ulrich R. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Virology 273 (2000) 21-35
15. Gedvilaite A., Zvirbliene A., Staniulis J., Sasnauskas K., Krüger D.H., and Ulrich R. Segments of Puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol. 17 (2004) 51-68
16. Gleiter S., Stubenrauch K., and Lilie H. Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Protein Sci. 8 (1999) 2562-2569
17. Guermonprez P., Valladeau J., Zitvogel L., Thery C., and Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 20 (2002) 621-667
18. Knowles W.A., Pipkin P., Andrews N., Vyse A., Minor P., Brown D.W., and Miller E. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71 (2003) 115-123
19. Kosukegawa A., Arisaka F., Takayama M., Yajima H., Kaidow A., and Handa H. Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells. Biochem. Biophys. Acta 1290 (1996) 37-45
20. Lenz P., Day P.M., Pang Y.Y., Frye S.A., Jensen P.N., Lowy D.R., and Schiller J.T. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166 (2001) 5346-5355
21. Montross L., Watkins S., Moreland R.B., Mamon H., Caspar D.L.D., and Garcea R.L. Nuclear assembly of polyoma capsids in insect cells expressing the major capsid protein VP1. J. Virol. 65 (1991) 4991-4998
22. Moser J.M., and Lukacher A.E. Immunity to polyoma virus infection and tumorigenesis. Viral Immunol. 14 (2001) 199-216
23. Moser J.M., Gibbs J., Jensen P.E., and Lukacher A.E. CD94-NKG2A receptors regulate antiviral CD8(+) T cell responses. Nat. Immunol. 3 (2002) 189-195
24. Noad R., and Roy P. Virus-like particles as immunogens. Trends Microbiol. 11 (2003) 438-444
25. Pawlita M., Müller M., Oppenlander M., Zentgraf H., and Herrmann M. DNA encapsidation by viruslike particles assembled in insect cells from the major capsid protein VP1 of B-lymphotropic papovavirus. J. Virol. 70 (1996) 7517-7526
26. Pecher G., Haring A., Kaiser L., and Thiel E. Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol. Immunother. 51 (2002) 669-673
27. Peng S., Zhou J., and Frazer I.H. Construction and production of fluorescent papillomavirus-like particles. J. Tongji Med. Univ. 19 (1999) 170-174
28. Pumpens P., and Grens E. Artificial genes for chimeric virus-like particles. In: Khudyakov Y.E., and Fields H.A. (Eds). Artificial DNA. Methods and Applications (2002), CRC Press LLC, Boca Raton 249-327
29. Salter R.D., and Dong X. Regulation of antigen capture, MHC biosynthesis, and degradation by dendritic cells. In: Lotze T.M., and Thomson A.W. (Eds). Dendritic Cells (2001), Academic Press, Inc., San Diego, CA 151-163
30. Salunke D.M., Caspar D.L.D., and Garcea R.L. Self-assembly of purified polyomavirus capsid protein VP1. Cell 46 (1986) 895-904
31. Sasnauskas K., Buzaite O., Vogel F., Jandrig B., Razanskas R., Staniulis J., Scherneck S., Krüger D.H., and Ulrich R. Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol. Chem. 380 (1999) 381-386
32. Sasnauskas K., Bulavaite A., Hale A., Jin L., Knowles W.A., Gedvilaite A., Dargeviciute A., Bartkeviciute D., Zvirbliene A., Staniulis J., Brown D.W., and Ulrich R. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae. Intervirology 45 (2002) 308-317
33. Scherneck S., Ulrich R., and Feunteun J. The hamster polyomavirus-A brief review of recent knowledge. Virus Genes 22 (2001) 93-101
34. Schmidt U., Kenklies J., Rudolph R., and Böhm G. Site-specific fluorescence labelling of recombinant polyomavirus-like particles. Biol. Chem. 380 (1999) 397-401
35. Stehle T., Yan Y., Benjamin T.L., and Harrison S.C. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369 (1994) 160-163
36. Szomolanyi-Tsuda E., Le Q.P., Garcea R.L., and Welsh R.M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J. Virol. 72 (1998) 6665-6670
37. Szomolanyi-Tsuda E., Brien J.D., Dorgan J.E., Garcea R.L., Woodland R.T., and Welsh R.M. Antiviral T-cell-independent type 2 antibody responses induced in vivo in the absence of T and NK cells. Virology 280 (2001) 160-168
38. Tegerstedt K., Andreasson K., Vlastos A., Hedlund K.O., Dalianis T., and Ramqvist T. Murine pneumotropic virus VP1 virus-like particles (VLPs) bind to several cell types independent of sialic acid residues and do not serologically cross react with murine polyomavirus VP1 VLPs. J. Gen. Virol. 84 (2003) 3443-3452
39. Tegerstedt K., Franzen A.V., Andreasson K., Joneberg J., Heidari S., Ramqvist T., and Dalianis T. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer. Anticancer Res. 25 (2005) 2601-2608
40. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., and Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22 (2003) 4346-4355
41. Ulrich R., Nassal M., Meisel H., and Krüger D.H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50 (1998) 141-182
42. In: Ulrich R., Lomonossoff G.P., and Krüger D.H. (Eds). New Developments in Viral Vaccine Technologies. Thematic Issue. Intervirology vol. 45 (2002) 4-6
43. Velupillai P., Garcea R.L., and Benjamin T.L. Polyoma virus-like particles elicit polarized cytokine responses in APCs from tumor-susceptible and-resistant mice. J .Immunol. 176 (2006) 1148-1153
44. Vlastos A., Andreasson K., Tegerstedt K., Hollanderova D., Heidari S., Forstova J., Ramqvist T., and Dalianis T. VP1 pseudocapsids, but not a glutathione-S-transferase VP1 fusion protein, prevent polyomavirus infection in a T-cell immune deficient experimental mouse model. J. Med. Virol. 70 (2003) 293-300
45. Voronkova T., Grosch A., Kazaks A., Ose V., Skrastina D., Sasnauskas K., Jandrig B., Arnold W., Scherneck S., Pumpens P., and Ulrich R. Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice. Viral Immunol. 15 (2002) 627-644
46. Voronkova, T., Kazaks, A., Ose, V., Özel, M., Scherneck, S., Pumpens, P., Ulrich, R., in press. Hamster polyomavirus-derived virus-like particles are able to transfer in vitro encapsidated plasmid DNA to mammalian cells. Virus Genes.
47. Welsh R.M., Stepp S.E., Szomolanyi-Tsuda E., and Peacock C.D. Tumor viral escape from inhibited T cells. Nat. Immunol. 3 (2002) 112-114
48. Zielonka A., Gedvilaite A., Ulrich R., Lüschow D., Sasnauskas K., Müller H., and Johne R. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests. Virus Res. 120 (2006) 128-137
49. Zvirbliene A., Samonskyte L., Gedvilaite A., Voronkova T., Ulrich R., and Sasnauskas K. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles. J. Immunol. Methods 311 (2006) 57-70